Articles

BHS clinical guidelines on the management of acute complications in sickle cell disease

BJH - volume 10, issue 4, june 2019

T. van Genechten MD, A. Vanderfaeillie MD, M.A. Azerad MD, D. Kieffer PhD, PharmD, V. Labarque MD, PhD, B. Gulbis MD, PhD, A. Ferster MD, PhD, B. De Wilde MD, PhD

With the increasing prevalence of sickle cell disease patients in Western countries, it is of importance to improve awareness among medical doctors of its complications. To reduce long-term morbidity and mortality, the prompt recognition and treatment of acute complications is important. The existing clinical guideline ‘Follow-up and treatment of patients with sickle cell disease hospitalised for Vaso Occlusive Crisis or infection’, published in 2012 by the Belgian Haematological Society, was revisited to better suit the practical needs of first-line practitioners.

(BELG J HEMATOL 2019;10(4):165–8)

Read more

PP55 Post-transfusion HbS monitoring on TOSOH G8 in variant HbA1c mode

BJH - volume 8, issue Abstract Book BHS, february 2017

S. van Aelst , K. Desmet , E. Nackers , D. Kieffer PhD, PharmD

Read more

P36 Next generation sequencing in patients with therapy-related myeloid neoplasms

BJH - volume 8, issue Abstract Book BHS, february 2017

H. Claerhout MD, E. Lierman PhD, D. Kieffer PhD, PharmD, N. Boeckx MD, PhD

Read more

P57 Comparison of the a-Globin StripAssay® and MLPA® as a diagnostic tool for a-thalassaemia

BJH - volume 8, issue Abstract Book BHS, february 2017

H. Claerhout MD, J. Oosterbosch , C.L. Harteveld , E. Lierman PhD, D. Kieffer PhD, PharmD

Read more
X